Shanghai Haohai Biological Technology Co., Ltd. released a Next Day Disclosure Return dated 4 November 2025. The document confirms that the company’s H-share count remains at 38,529,240. A series of H-share repurchases have been recorded but not yet canceled, including 43,000 shares repurchased on 4 November 2025 at an average price of HKD 27.64.
For A shares, the total stands at 190,203,760 and 3,848,095 treasury shares, making for an overall total of 194,051,855. No additional A-share changes occurred on 4 November 2025. According to the disclosure, 330,200 H shares have been repurchased under a board-approved mandate dated 10 June 2025, which authorizes a maximum of 3,914,184 shares to be bought back. The mandate imposes a 30-day moratorium on certain new share issuances or related transfers following any repurchase, set to last until 4 December 2025.